10-95611185-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002860.4(ALDH18A1):​c.2110+71C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.124 in 1,573,114 control chromosomes in the GnomAD database, including 12,845 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1031 hom., cov: 33)
Exomes 𝑓: 0.13 ( 11814 hom. )

Consequence

ALDH18A1
NM_002860.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.251

Publications

2 publications found
Variant links:
Genes affected
ALDH18A1 (HGNC:9722): (aldehyde dehydrogenase 18 family member A1) This gene is a member of the aldehyde dehydrogenase family and encodes a bifunctional ATP- and NADPH-dependent mitochondrial enzyme with both gamma-glutamyl kinase and gamma-glutamyl phosphate reductase activities. The encoded protein catalyzes the reduction of glutamate to delta1-pyrroline-5-carboxylate, a critical step in the de novo biosynthesis of proline, ornithine and arginine. Mutations in this gene lead to hyperammonemia, hypoornithinemia, hypocitrullinemia, hypoargininemia and hypoprolinemia and may be associated with neurodegeneration, cataracts and connective tissue diseases. Alternatively spliced transcript variants, encoding different isoforms, have been described for this gene. [provided by RefSeq, Jul 2008]
ALDH18A1 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 3
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • ALDH18A1-related de Barsy syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive complex spastic paraplegia type 9B
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • P5CS deficiency
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • hereditary spastic paraplegia 9A
    Inheritance: AD, SD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • autosomal dominant complex spastic paraplegia type 9B
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 10-95611185-G-C is Benign according to our data. Variant chr10-95611185-G-C is described in ClinVar as Benign. ClinVar VariationId is 1242768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002860.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALDH18A1
NM_002860.4
MANE Select
c.2110+71C>G
intron
N/ANP_002851.2
ALDH18A1
NM_001323413.2
c.2110+71C>G
intron
N/ANP_001310342.1
ALDH18A1
NM_001323414.2
c.2110+71C>G
intron
N/ANP_001310343.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALDH18A1
ENST00000371224.7
TSL:1 MANE Select
c.2110+71C>G
intron
N/AENSP00000360268.2
ALDH18A1
ENST00000371221.3
TSL:1
c.2104+71C>G
intron
N/AENSP00000360265.3
ALDH18A1
ENST00000485428.1
TSL:2
n.*71C>G
downstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.106
AC:
16141
AN:
152114
Hom.:
1031
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0491
Gnomad AMI
AF:
0.0768
Gnomad AMR
AF:
0.101
Gnomad ASJ
AF:
0.215
Gnomad EAS
AF:
0.0408
Gnomad SAS
AF:
0.0731
Gnomad FIN
AF:
0.154
Gnomad MID
AF:
0.225
Gnomad NFE
AF:
0.136
Gnomad OTH
AF:
0.130
GnomAD4 exome
AF:
0.126
AC:
178576
AN:
1420882
Hom.:
11814
AF XY:
0.125
AC XY:
88721
AN XY:
708410
show subpopulations
African (AFR)
AF:
0.0447
AC:
1456
AN:
32602
American (AMR)
AF:
0.0753
AC:
3361
AN:
44626
Ashkenazi Jewish (ASJ)
AF:
0.200
AC:
5185
AN:
25868
East Asian (EAS)
AF:
0.0374
AC:
1472
AN:
39402
South Asian (SAS)
AF:
0.0796
AC:
6784
AN:
85226
European-Finnish (FIN)
AF:
0.159
AC:
8487
AN:
53216
Middle Eastern (MID)
AF:
0.178
AC:
765
AN:
4286
European-Non Finnish (NFE)
AF:
0.133
AC:
143680
AN:
1076746
Other (OTH)
AF:
0.125
AC:
7386
AN:
58910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
8014
16028
24042
32056
40070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4994
9988
14982
19976
24970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.106
AC:
16136
AN:
152232
Hom.:
1031
Cov.:
33
AF XY:
0.105
AC XY:
7843
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0490
AC:
2036
AN:
41556
American (AMR)
AF:
0.100
AC:
1535
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
745
AN:
3468
East Asian (EAS)
AF:
0.0411
AC:
213
AN:
5186
South Asian (SAS)
AF:
0.0732
AC:
353
AN:
4824
European-Finnish (FIN)
AF:
0.154
AC:
1633
AN:
10596
Middle Eastern (MID)
AF:
0.224
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
0.135
AC:
9213
AN:
67998
Other (OTH)
AF:
0.129
AC:
272
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
747
1495
2242
2990
3737
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0417
Hom.:
48
Bravo
AF:
0.101

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
11
DANN
Benign
0.69
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2296690; hg19: chr10-97370942; COSMIC: COSV64663761; COSMIC: COSV64663761; API